Nanomedicine News

RSS
Scottish Medicines Consortium Recommends ABRAXANE-Gemcitabine Combination for Metastatic Pancreatic Cancer Treatment

Scottish Medicines Consortium Recommends ABRAXANE-Gemcitabine Combination for Metastatic Pancreatic Cancer Treatment

New Report on Global Transdermal Drug Delivery Market

New Report on Global Transdermal Drug Delivery Market

Novel 3D Vaccine Offers More Effective Method to Harness the Immune System to Fight Cancer

Novel 3D Vaccine Offers More Effective Method to Harness the Immune System to Fight Cancer

Vaxxas Secures A$25 Million Equity Funding to Advance Clinical Programs Using Nanopatch Vaccine Platform

Vaxxas Secures A$25 Million Equity Funding to Advance Clinical Programs Using Nanopatch Vaccine Platform

PEG-HCC Nanoparticle Can Catalyze Neutralization of Damaging Reactive Oxygen Species Molecules

PEG-HCC Nanoparticle Can Catalyze Neutralization of Damaging Reactive Oxygen Species Molecules

Biology Major Co-Authors Nature Nanotechnology Paper on siRNA Delivery Research

Biology Major Co-Authors Nature Nanotechnology Paper on siRNA Delivery Research

Small, Low Cost Microfluidic Device to Rapidly Detect Allergies or Diseases

Small, Low Cost Microfluidic Device to Rapidly Detect Allergies or Diseases

Quantum Rattles with Gold Nanoparticles Can Penetrate the Center of Cells

Quantum Rattles with Gold Nanoparticles Can Penetrate the Center of Cells

Lundbeck Funding Enables Joint Professorship in Drug Delivery and Nanomedicine

Lundbeck Funding Enables Joint Professorship in Drug Delivery and Nanomedicine

Nano-Hydrogels Transport Drugs Directly to Cancer Cells

Nano-Hydrogels Transport Drugs Directly to Cancer Cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.